Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Ocean Biomedical, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2024
- Shares held
- 3.68M
- +96.6K (+2.7%) vs. Q3 2024
- Total value
- $2.01M
- −$1.46M (−42.1%) vs. Q3 2024
- New holders
- 4
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 7 | $5.69K |
| Q1 2025 | 25 | $247.3K |
| Q4 2024 | 22 | $2.01M |
| Q3 2024 | 21 | $3.46M |
| Q2 2024 | 36 | $4.77M |
| Q1 2024 | 46 | $17.1M |
| Q4 2023 | 35 | $3.02M |
| Q3 2023 | 39 | $24.2M |
| Q2 2023 | 35 | $40.6M |
| Q1 2023 | 17 | $47.6M |
| Q4 2022 | 43 | $108.1M |
| Q3 2022 | 40 | $105.9M |
| Q2 2022 | 35 | $102.9M |
| Q1 2022 | 34 | $99.4M |
| Q4 2021 | 26 | $81.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Ocean Biomedical, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,688,193 | $1.46M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 406,529 | $224.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 175,308 | $97.0K | 0.00% | +34,317+24.3% | Added |
| Millennium Management LLC | 124,895 | $69.1K | 0.00% | −2,667−2.1% | Reduced |
| BlackRock, Inc. | 60,877 | $33.7K | 0.00% | +126+0.2% | Added |
| UBS Group AG | 55,147 | $30.5K | 0.00% | +54,995+36,180.9% | Added |
| Citadel Advisors LLC | 39,195 | $21.7K | 0.00% | +6,287+19.1% | Added |
| State Street Corp | 32,800 | $18.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,775 | $14.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,450 | $11.3K | 0.00% | +20,450 | New |
| Bank of Montreal | 20,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| ACT Advisors, LLC. | 15,911 | $8.80K | 0.00% | −790−4.7% | Reduced |
| Tower Research Capital LLC (TRC) | 5,511 | $3.05K | 0.00% | +928+20.2% | Added |
| Citigroup Inc | 4,800 | $2.65K | 0.00% | +4,009+506.8% | Added |
| FMR LLC | 792 | $438 | 0.00% | −1,647−67.5% | Reduced |
| JPMorgan Chase & Co | 236 | $131 | 0.00% | +27+12.9% | Added |
| Farther Finance Advisors, LLC | 183 | $101 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 143 | $79 | 0.00% | +143 | New |
| Bank of America Corp | 87 | $48 | 0.00% | −142−62.0% | Reduced |
| SBI Securities Co., Ltd. | 17 | $9 | 0.00% | +17 | New |
| FNY Investment Advisers, LLC | 600 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,555 | $0 | 0.00% | +1,555 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,562−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −399−100.0% | Sold out |